Met Life Investment Management, LLC Dyne Therapeutics, Inc. Transaction History

Met Life Investment Management, LLC

$20.1 Billion
Q3 2025

A detailed history of Met Life Investment Management, LLC transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 64,221 shares of DYN stock, worth $1.21 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

64,221

Previous 56,844 12.98%

Holding current value

$1.21 Million

Previous $541,000 50.09%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$8.18 - $14.22 $60,343 - $104,900	7,377 Added 12.98%	64,221 $812,000
Q2 2025 Aug 13, 2025	BUY	$6.81 - $14.78 $54,806 - $118,949	8,048 Added 16.49%	56,844 $541,000
Q1 2025 May 14, 2025	SELL	$10.46 - $25.46 $7,018 - $17,083	-671 Reduced 1.36%	48,796 $510,000
Q4 2024 Feb 13, 2025	BUY	$23.56 - $35.55 $64,742 - $97,691	2,748 Added 5.88%	49,467 $1.17 Million
Q2 2024 Aug 13, 2024	BUY	$23.65 - $35.63 $384,005 - $578,524	16,237 Added 53.27%	46,719 $1.65 Million

Q1 2024 May 14, 2024	BUY	$13.06 - $29.18 $398,094 - $889,464	30,482 New	30,482 $865,000
Q3 2023 May 09, 2024	BUY	$8.6 - $12.18 $27,236 - $38,574	3,167 Added 16.02%	22,933 $205,000
Q2 2023 Apr 29, 2024	BUY	$8.53 - $14.28 $195,618 - $327,483	22,933 New	22,933 $257,000
Q2 2023 Aug 10, 2023	BUY	$8.53 - $14.28 $27,014 - $45,224	3,167 Added 16.02%	22,933 $257,000
Q1 2023 May 09, 2024	BUY	$10.88 - $15.0 $215,054 - $296,490	19,766 New	19,766 $228 Million
Q1 2022 May 10, 2024	BUY	$6.52 - $12.27 $128,874 - $242,528	19,766 New	19,766 $190,000
Q1 2022 Mar 22, 2023	BUY	$6.52 - $12.27 $46,813 - $88,098	7,180 Added 57.05%	19,766 $190,000
Q1 2022 May 12, 2022	BUY	$6.52 - $12.27 $46,813 - $88,098	7,180 Added 57.05%	19,766 $191,000
Q4 2021 Jun 21, 2023	SELL	$11.89 - $16.07 $85,370 - $115,382	-7,180 Reduced 36.33%	12,586 $149,000
Q3 2021 Jun 21, 2023	SELL	$15.6 - $21.46 $112,008 - $154,082	-7,180 Reduced 36.33%	12,586 $204,000
Q2 2021 May 17, 2024	SELL	$15.94 - $22.33 $285,262 - $399,617	-17,896 Reduced 58.71%	12,586 $264,000
Q2 2021 Jun 21, 2023	SELL	$15.94 - $22.33 $114,449 - $160,329	-7,180 Reduced 36.33%	12,586 $264,000
Q2 2021 Mar 22, 2023	BUY	$15.94 - $22.33 $81,405 - $114,039	5,107 Added 68.28%	12,586 $264,000
Q2 2021 Aug 16, 2021	BUY	$15.94 - $22.33 $200,620 - $281,045	12,586 New	12,586 $265,000
Q1 2021 May 14, 2021	SELL	$14.0 - $29.3 $104,706 - $219,134	-7,479 Closed	0 $0
Q4 2020 May 24, 2024	SELL	$16.81 - $23.94 $386,680 - $550,691	-23,003 Reduced 75.46%	7,479 $157,000
Q4 2020 Jun 22, 2023	SELL	$16.81 - $23.94 $206,544 - $294,150	-12,287 Reduced 62.16%	7,479 $157,000
Q4 2020 Mar 22, 2023	SELL	$16.81 - $23.94 $206,544 - $294,150	-12,287 Reduced 62.16%	7,479 $157,000
Q4 2020 Feb 16, 2021	BUY	$16.81 - $23.94 $125,721 - $179,047	7,479 New	7,479 $157,000

Others Institutions Holding DYN

# of Institutions

227

Shares Held

148M

Call Options Held

184K

Put Options Held

243K

View Full List

About Dyne Therapeutics, Inc.

Ticker DYN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,765,400
Market Cap $975M
Description
Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...

More about DYN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Account

Met Life Investment Management, LLC Dyne Therapeutics, Inc. Transaction History